Table 2.
Baseline | 6 Weeks (Pre-intervention) | 12 Weeks (Post-intervention) | Change: Baseline to 6 Weeks (control phase) | Change: 6 to 12 weeks (intervention phase) | P-value* | |
---|---|---|---|---|---|---|
Composite Y-balance score † | 88.30 ± 6.89 | 89.98 ± 6.18 | 91.27 ± 5.79 | 1.67 ± 5.34 | 1.29 ± 4.36 | 0.16 |
Hip FPPA (°) | 24.25 ± 4.56 | 22.87 ± 6.01 | 18.75 ± 6.15 | −0.9 ± 4.3 | −4.1 ± 7.2 | 0.0006* |
Knee FPPA (°) | 22.22 ± 8.65 | 18.93 ± 10.78 | 8.54 ± 9.96 | −2.3 ± 5.4 | −10.4 ± 12.9 | <0.0001* |
Pain during Y-balance (VAS) | 24.39 ± 17.33 | 28.70 ± 21.16 | 6.09 ± 10.08 | 4.30 ± 9.68 | −22.6 ± 20.45 | <0.0001*# |
Lateral Rotator Strength (N) | 106.6 ± 21.43 | 104.6 ± 18.76 | 111.0 ± 16.40 | −1.9 ± 9.9 | 6.4 ± 10.3 | 0.003* |
Hip Abductor Strength (N) | 86.90 ± 26.96 | 87.03 ± 22.32 | 96.63 ± 21.67 | 0.1 ± 18.6 | 9.6 ± 16.9 | 0.005* |
Hip Extensor Strength (N) | 158.7 ± 40.60 | 160.1 ± 39.29 | 173.8 ± 38.53 | 1.4 ± 31.8 | 13.7 ± 30.2 | 0.04* |
SD = Standard Deviation; FPPA=frontal plane projection angle; N=newtons; VAS= visual analog scale
P-value: change during intervention phase compared to change during control phase (statistically significant at 0.05 alpha level)
values reported as % of leg length
Prior to analysis, data were log transformed to follow the multivariate normal distribution.